Aaron Rosenberg insider trades: BeOne Medicines (ONC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Aaron reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | ONC | ↓ Sell | 1,157 | $312.71 | $362K | Direct | Aug 5, 2026 (2d) |
| Jun 11, 2026 | ONC | ↓ Sell | 631 | $257.74 | $163K | Direct | Jun 15, 2026 (4d) |
| Aug 1, 2025 | ONC | ↓ Sell | 1,190 | $290.47 | $346K | Direct | Aug 5, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ONC insiders
Open-market trades in the last 12 months
About Aaron Rosenberg's insider trades
Aaron Rosenberg is Chief Financial Officer at BeOne Medicines (ONC). Since Aug 1, 2025, Aaron has reported no open-market purchases and 3 sales worth $870K on SEC Form 4. In the last 12 months: 2 sales ($524K).
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.